Search Results 611-620 of 12025 for Lupus

1. Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic Kidney Disease - Mayo Clinic

   ... lupus nephritis, amyloidosis, or other monoclonal gammopathy of renal significance 7. Autosomal dominant or recessive polycystic kidney disease 8. Nephrotic ...

2. A Study Investigating the Safety, Tolerability, Pharmacokinetics, and Effectiveness of Mosunetuzumab (BTCT4465A) in Combination With CHOP or CHP-Polatuzumab Vedotin in Participants With B-Cell Non-Hodgkin Lymphoma - Mayo Clinic

   History of autoimmune disease, including, but not limited to, myasthenia gravis, myositis, autoimmune hepatitis, systemic lupus erythematosus, rheumatoid ...

3. A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients with Recurrent Glioblastoma with Elevated Mutational Burden - Mayo Clinic

   ... lupus erythematosus (SLE), connective tissue diseases, scleroderma, inflammatory bowel disease (IBD), Crohn's, ulcerative colitis, hepatitis; and patients ...

4. Brain tumor - Symptoms and causes - Mayo Clinic

   Find out more about the different types, signs, symptoms and causes of brain tumors, which are growths of cells in the brain.

5. Study Treating Patients with Relapsed or Refractory Aggressive B-cell Lymphomas Using Nivolumab with or without Varlilumab - Mayo Clinic

   ... lupus erythematosus (SLE), connective tissue diseases, scleroderma, inflammatory bowel disease (IBD), Crohn's, ulcerative colitis, hepatitis; and patients ...

6. A Study to Evaluate Chemoradiotherapy with or without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer - Mayo Clinic

   Autoimmune diseases include, but are not limited to, systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, vascular thrombosis ...

7. Nemolizumab-Ilto (Subcutaneous Route) Precautions - Mayo Clinic

   This medicine may cause serious allergic reaction, including angioedema, which can be life-threatening and require immediate medical attention.

8. A Study Comparing BGB-3111 and Ibrutinib in Subjects With Waldenström's Macroglobulinemia (WM) - Mayo Clinic

   Subjects with factor inhibitors that prolong PT/aPTT without increasing the bleeding risk, or those with lupus anticoagulant or acquired von Willebrand's ...

9. Autoimmune neurology: Enhanced expertise for treatable conditions - Mayo Clinic

   Mayo Clinic is augmenting its team of autoimmune neurology clinician-researchers. The move epitomizes Mayo Clinic's commitment to excellence in the field.

10. Impact of Liver INR, an Alternatively Calibrated INR, on MELD Scores in Chronic Liver Disease Patients - Mayo Clinic

    Exclude use of drugs known to interfere with coagulation tests (heparin, warfarin, direct thrombin inhibitors, direct factor Xa inhibitor, lupus coagulant) ...